PlainRecalls
FDA Drug Moderate Class II Terminated

Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.

Reported: June 17, 2015 Initiated: April 17, 2015 #D-1116-2015

Product Description

Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.

Reason for Recall

Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.

Details

Units Affected
93,237 Bottles
Distribution
United States Nationwide
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.. Recalled by Valeant Pharmaceuticals North America LLC. Units affected: 93,237 Bottles.
Why was this product recalled?
Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 17, 2015. Severity: Moderate. Recall number: D-1116-2015.